NIAID supports the study of global research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases and conditions. In addition to advancing these scientific goals, NIAID global research helps to improve the health of millions of people around the world, to protect the United States against infectious disease threats, and to promote international economic and political stability. Together, these efforts establish NIAID as a leader in global health.
NIH-Sponsored Study Identifies Superior Drug Regimen for Preventing Mother-to-Child HIV Transmission—Nov. 17, 2014
Bulletin: In South Africa, RV144 HIV Vaccine Regimen Induces Immune Responses Similar to Those Seen in Thailand—Oct. 28, 2014
NIH Begins Early Human Clinical Trial of VSV Ebola Vaccine—Oct. 22, 2014
Media Availability: NIH Grants License Agreement for Candidate Ebola Vaccines—Oct. 15, 2014
All Global Research News Releases
News From NIAID-Supported Institutions
Last Updated November 18, 2014